238 related articles for article (PubMed ID: 15252850)
21. Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines.
Kjaergaard J; Wang LX; Kuriyama H; Shu S; Plautz GE
J Neurosurg; 2005 Jul; 103(1):156-64. PubMed ID: 16121986
[TBL] [Abstract][Full Text] [Related]
22. Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma.
Yoshida J; Mizuno M; Nakahara N; Colosi P
Jpn J Cancer Res; 2002 Feb; 93(2):223-8. PubMed ID: 11856487
[TBL] [Abstract][Full Text] [Related]
23. Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.
Yamanaka R; Zullo SA; Ramsey J; Yajima N; Tsuchiya N; Tanaka R; Blaese M; Xanthopoulos KG
J Neurosurg; 2002 Sep; 97(3):611-8. PubMed ID: 12296646
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.
Pellegatta S; Poliani PL; Corno D; Grisoli M; Cusimano M; Ubiali F; Baggi F; Bruzzone MG; Finocchiaro G
Neurol Res; 2006 Jul; 28(5):527-31. PubMed ID: 16808884
[TBL] [Abstract][Full Text] [Related]
25. Antitumor efficacy of argon-helium cryoablation-generated dendritic cell vaccine in glioma.
Yin Z; Lu G; Xiao Z; Liu T; He X; Wang Q; Lin C; Zhang S
Neuroreport; 2014 Mar; 25(4):199-204. PubMed ID: 24445619
[TBL] [Abstract][Full Text] [Related]
26. DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.
Maes W; Rosas GG; Verbinnen B; Boon L; De Vleeschouwer S; Ceuppens JL; Van Gool SW
Neuro Oncol; 2009 Oct; 11(5):529-42. PubMed ID: 19336528
[TBL] [Abstract][Full Text] [Related]
27. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
28. Basic study on gene therapy of human malignant glioma by use of the cationic multilamellar liposome-entrapped human interferon beta gene.
Yagi K; Ohishi N; Hamada A; Shamoto M; Ohbayashi M; Ishida N; Nagata A; Kanazawa S; Nishikimi M
Hum Gene Ther; 1999 Aug; 10(12):1975-82. PubMed ID: 10466631
[TBL] [Abstract][Full Text] [Related]
29. Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.
Maes W; Van Gool SW
Cancer Immunol Immunother; 2011 Feb; 60(2):153-60. PubMed ID: 21120655
[TBL] [Abstract][Full Text] [Related]
30. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
Yu JS; Liu G; Ying H; Yong WH; Black KL; Wheeler CJ
Cancer Res; 2004 Jul; 64(14):4973-9. PubMed ID: 15256471
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
Kawano M; Itonaga I; Iwasaki T; Tsumura H
Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
[TBL] [Abstract][Full Text] [Related]
32. Cell therapies in neuro-oncology.
Pellegatta S; Finocchiaro G
Neurol Sci; 2005 May; 26 Suppl 1():S43-5. PubMed ID: 15883693
[TBL] [Abstract][Full Text] [Related]
33. [Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors].
Xiao ZY; Chen XJ; Yang Y; Xu RX
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):661-6. PubMed ID: 26284406
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy for malignant gliomas.
Bloch O
Cancer Treat Res; 2015; 163():143-58. PubMed ID: 25468230
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of antitumor activity by combination of tumor lysate-pulsed dendritic cells and celecoxib in a rat glioma model.
Zhang H; Tian M; Xiu C; Wang Y; Tang G
Oncol Res; 2013; 20(10):447-55. PubMed ID: 24308155
[TBL] [Abstract][Full Text] [Related]
36. Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment.
Pellegatta S; Poliani PL; Stucchi E; Corno D; Colombo CA; Orzan F; Ravanini M; Finocchiaro G
Neuro Oncol; 2010 Apr; 12(4):377-88. PubMed ID: 20308315
[TBL] [Abstract][Full Text] [Related]
37. A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma.
Rudnick JD; Sarmiento JM; Uy B; Nuno M; Wheeler CJ; Mazer MJ; Wang H; Hu JL; Chu RM; Phuphanich S; Black KL; Yu JS
J Clin Neurosci; 2020 Apr; 74():187-193. PubMed ID: 32169363
[TBL] [Abstract][Full Text] [Related]
38. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
[TBL] [Abstract][Full Text] [Related]
39. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.
Pellegatta S; Poliani PL; Corno D; Menghi F; Ghielmetti F; Suarez-Merino B; Caldera V; Nava S; Ravanini M; Facchetti F; Bruzzone MG; Finocchiaro G
Cancer Res; 2006 Nov; 66(21):10247-52. PubMed ID: 17079441
[TBL] [Abstract][Full Text] [Related]
40. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
Herrlinger U; Kramm CM; Johnston KM; Louis DN; Finkelstein D; Reznikoff G; Dranoff G; Breakefield XO; Yu JS
Cancer Gene Ther; 1997; 4(6):345-52. PubMed ID: 9408604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
